Andrew G. Long is Chief Executive Officer of INSYS Therapeutics. Mr. Long joined INSYS Therapeutics in August 2017 as the Chief Financial Officer bringing more than 25 years of financial strategy, transformation and executive experience in the life science and bio-pharma industries.
Prior to joining INSYS Therapeutics Mr. Long’s most recently served as Senior Vice President of Global Finance at Patheon, where he worked on a number of initiatives leading up to Patheon’s IPO. Prior to working at Patheon, Mr. Long spent nine years as Vice President of Finance for multiple divisions at Thermo Fisher Scientific. He began his career building financial expertise in various roles at Abbott Laboratories.
Mr. Long received his M.B.A. from the Kellogg School of Business at Northwestern University and earned his undergraduate degree in finance from Indiana University.